About
Contact & Profiles
A5043842671
Research Areas
- Breast Cancer Treatment Studies
- Cancer Cells and Metastasis
- Cancer Research and Treatments
- Single-cell and spatial transcriptomics
- Inflammatory Biomarkers in Disease Prognosis
- Peptidase Inhibition and Analysis
- Effects and risks of endocrine disrupting chemicals
- Glycosylation and Glycoproteins Research
- Global Cancer Incidence and Screening
- Cancer Risks and Factors
- Cancer-related gene regulation
- Ferroptosis and cancer prognosis
- Cancer Genomics and Diagnostics
- Medical Imaging Techniques and Applications
Second Affiliated Hospital of Xi'an Jiaotong University
2024-2025
Abstract Breast cancer has become the most commonly diagnosed cancer. The intra‐ and interpatient heterogeneity induced a considerable variation in treatment efficacy. There is an urgent requirement for preclinical models to anticipate effectiveness of individualized drug responses. Patient‐derived organoids (PDOs) can accurately recapitulate architecture biological characteristics origin tumor, making them promising model that overtake many limitations cell lines PDXs. However, it still...
10.1002/ijc.34931
article
EN
cc-by-nc-nd
International Journal of Cancer
2024-03-27
10.1186/s12302-025-01071-3
article
EN
cc-by-nc-nd
Environmental Sciences Europe
2025-03-09
10.1038/s41598-025-03331-x
article
EN
cc-by-nc-nd
Scientific Reports
2025-05-26
10.1016/j.lfs.2024.123193
article
EN
Life Sciences
2024-10-30
10.2139/ssrn.4860704
preprint
EN
2024-01-01
10.1016/j.ijrobp.2022.07.760
article
EN
International Journal of Radiation Oncology*Biology*Physics
2022-10-22
10.1016/j.ijrobp.2022.07.732
article
EN
International Journal of Radiation Oncology*Biology*Physics
2022-10-22
Coming Soon ...